References
- Alberti, K. G., Zimmet, P., Shaw, J. (2005). The metabolic syndrome — a new worldwide definit on. Lancet, 366 (9491), 1059–1062.
- Anonīms (2011). Latvijas veselības statistikas gadagrāmata par 2010. gadu [Annual Book of Latvian Health Statistics about 2010]. Rīga: VSMTVA (Veselības statistikas un medicīnas tehnoloìiju valsts aìentûra) (in Latvian).
- Anonīms (2013a). Lokren zāïu paraksts. http://www.zva.gov.lv/zalu-registrs/?iss=1&lang=lv&q=Betax&ON=&S N=&NAC=on&RN=&ESC=on&AK=&SAT=on&RA=&DEC=on&LB= &PIM=on (last accessed 20.07.2013).
- Anonymous (2013b). Procoralan SPC (Summary of Product Characteristics). http://www.ema.europa.eu/docs/lv_LV/document_library/EPAR_-_Product_Information/human/000597/WC500043590.pdf (last accessed 20.07.2013). Çrglis, A. (2010). Current state of angina treatment in the outpatient population and heart rate monitoring survey in Latvia (REALITY Latvia). Proc. Latvian Acad. Sci. Sect. B, 64 (5/6), 194–201.
- Balode, I., Jēgere, S., Mintāle, I., Narbute, I., Zakke, I., Latkovskis, G., Ērglis, A. (2010). Current state of angina treatment in the outpatient population and heart rate monitoring survey in Latvia (REALITY Latvia). Proc. Latvian Acad. Sci. Sect. B, 64 (5/6), 194–201.
- Balode, I., Jēgere, S., Mintāle, I., Narbute, I., I., Latkovskis, G., Çrglis, A. (2011) Heart rate and other risk factors in outpatients with stable coronary artery disease in Latvia. Proc. Latvian Acad. Sci. Sect. B, 65 (3/4), 94–101.
- Bohm, M., Swedberg, K., Komajda, M., Borer, J., Ford, I., Dubost-Brama, A., Lerebous, G., Tavazzi, L., on behalf of the SHIFT investigators (2010). Heart rate as a risk factor in chronic heart failure (SHIFT): The association between heart rate and outcomes in a randomised placebo-controlled trial. Lancet, 376 (9744), 886–94.
- Daly, C. A., De Stavola, B., Lopez-Sendon, J. L., Tavazzi, L, Boersma, E., Clemens, F., Danchin, N., Delahaye, F., Gitt, A., Julian, D., Mulcahy, D., Ruzyllo, W., Thygesen, K., Verheugt, F., Fox K. M. (2006) Predicting prognosis in stable angina — results from the Euro Heart Survey of stable angina: Prospective observational study. BMJ, 332, 262–267.
- Daly, C., Tavazzi, L., Fox, K., Euro Heart Survey of Angina Investigators (2008). Inadequate control of heart rate in patients with stable angina: Results from the European Heart Survey. Eur. Heart J., 29 (Abstract Supplement), 204.
- Diaz, A., Bourassa, M. G., Guertin, M. C., Tardif, J. C. (2005). Long term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease. Eur. Heart J., 26 (10), 967–974.
- Çrglis, A., Kalvelis, A., Lejnieks, A., Dzērve, V., Latkovskis, G., Mintāle, I., Zakke, I., Rasa, I. (2007). Kardiovaskulāro slimību (KVS) profilakses vadlīnijas [Guidelines on Cardiovascular Disease Prevention]. Rīga: Latvijas Kardiologu biedrība (in Latvian).
- Çrglis, A., Jēgere, S., Kalējs, O., Kalvelis, A., Kamzola, G., Lācis, J., Maèa, A., Mintāle, I., Narbute, I., Stradiòð, P., Zakke, I. (2012). Hroniskas sirds mazspējas klīniskās vadlīnijas [Guidelines on Heart Failure Management]. Rīga: Latvijas Kardiologu biedrība (in Latvian).
- Fox, K., Garcia, M. A. A., Ardissino, D., Buszman, P., Camici, P. G., Crea, F., Daly, C., Backer, G., Hjemdahl, P., Lopes-Sendon, J., Marco, J., Morais, J., Pepper, J., Sechtem, U., Simoons, M., Thygesen, K. (2006). Guidelines on the management of stable angina pectoris. The Task Force on the Managment of Stable Angina Pectoris of the European Society of Cardiology. Eur. Heart J., 27, 341–1381.
- Fox, K., Ford, I., Steg, P. G., Tendera, M., Robertson, M., Ferrari, R., BEAUTIFUL investigators (2008a). Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): A subgroup analysis of a randomised controlled trial. Lancet, 372 (9641), 817–821.
- Fox, K., Ford, I., Steg, P. G., Tendera, M., Ferrari, R., BEAUTIFUL investigators (2008b) Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): A randomised, double-blind, placebo-controlled trial. Lancet, 372, 807–816.
- Fox, K., Ford, I., Steg, P. G., Tendera, M., Robertson, M., Ferrari, R., BEAUTIFUL investigators (2009). Relationship between ivabradine treatment and cardiovascular outcomes in patients with stable coronary artery disease analysis of the randomized, controlled BEAUTIFUL trial. Eur. Heart J., 30, 2337–2345.
- Gislason, G. H., Rasmussen, J. N., Abildstrom, S. Z., Gadsboll, N., Buch, P., Friberg, J., Rasmussen, S., Kober, L., Stender, S., Madsen, M., and Torp-Pederden, C. (2006). Long term compliance with beta-blockers, angiotensin-converting inhiitors, and statins after acute myocardial infarction. Eur. Heart Journal, 27, 1153–1158.
- Graham, I., Atar, D., Borch-Johnsen, K., Boysen, G., Burell, G., Cifkova, R., Dallongeville, J., De Backer, G., Ebrahim, S., Gjelsvik, B., Herrmann-Lingen, C., Hoes, A., Humphries, S., Knapton, M., Perk, J., Priori, S. G., Pyorala, K., Reiner, Z., Ruilope, L., Sans-Menendez, S., Reimer, V. S. O., Weissberg, P., Wood, D., Yarnell, Y., Zamorano, J. L. (2007). European guidelines on cardiovascular disease prevention in clinical practice: Executive summary. Eur. Heart J., 28, 2375–2414.
- Leal, J., Luengo-Fernández, R., Gray, A., Petersen, S., Rayner, M. (2006). Economic burden of cardiovascular diseases in the enlarged European Union. Eur. Heart J., 27 (13), 1610–1619.
- Lopez-Sendon, J., Swedberg, K., McMurray J., Tamargo, J., Maggioni, A. P., Dargie, H., Tendera, M., Waagstein, F., Kjekshus, J., Lechat, P., Torp-Pedersen, C. (2004) Expert consensus document on ß-adrenergic receptor blockers. The Task Force on Beta-Blockers of the European Society of Cardiology. Eur. Heart J., 25, 1341–1362.
- Mathers, C. D., Loncar, D. (2006). Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med., Nov, 3, e442.
- McMurray, J. J. V., Adamopoulos, S., Anker, S. D., Auricchio, A., Bohm, M., Dickstein, K., Falk, V., Filippatos, G., Fonseca, C., Gomez-Sanchez, M. A., Jaarsm, T., K¸ber, L., Lip, G. Y. H., Maggioni, A. P., Parkhomenko, A., Pieske, B. M., Popescu, B. A., R¸nnevik, P. K., Rutten, F. H., Schwitter, J., Seferovic, P., Stepinska, J., Trindade, P.T., Voors, A. A., Zannad, F., Zeiher, A. (2012). ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur. Heart J., 33, 1787–1847.
- Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Z., Verschuren, W. M. M., Christian Albus, C., Benlian, P., Boysen, G., Cifkova, R., Deaton, C., Ebrahim, S., Fisher, M., Germano, G., Hobbs, R., Hoes, A., Karadeniz, S., Mezzani, A., Prescott, E., Ryden, L., Scherer, M., Syvanne, M., Scholte Op Reimer, W. J. M., Vrints, C., Wood, D., Zamorano, J. S. Zannad, F. (2012). European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). Eur. Heart J., 33, 1635–1701.
- Tunstall-Pedoe, H., Kuulasmaa, K., Mähönen, M., Tolonen, H., Ruokokoski, E., Amouyel, P., for the WHO MONICA (monitoring trends and determinants in cardiovascular disease) Project (1999). Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA Project populations. Lancet, 353, 1547–1557.
- Swedberg, K., Komajda, M., Bohm, M., Borer, J., Ford, I., Dubost-Brama, A., Lerebous, G., Tavazzi, L., on behalf of the SHIFT investigators (2010). Ivabradine and outcomes in chronic heart failure (SHIFT): A randomised placebo-controlled study. Lancet, 376, 875–885.